Rhumbline Advisers Icad Inc Transaction History

Rhumbline Advisers

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$3.02 - $4.56 $59,297 - $89,535	-19,635 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$3.92 - $7.48 $16,303 - $31,109	4,159 Added 26.87%	19,635 $88,000
Q4 2021 Feb 10, 2022	SELL	$6.7 - $11.38 $2,860 - $4,859	-427 Reduced 2.69%	15,476 $111,000
Q3 2021 Nov 12, 2021	BUY	$10.11 - $17.56 $10,362 - $17,999	1,025 Added 6.89%	15,903 $171,000
Q2 2021 Aug 05, 2021	SELL	$14.9 - $20.82 $7,405 - $10,347	-497 Reduced 3.23%	14,878 $258,000
Q1 2021 May 06, 2021	SELL	$12.57 - $21.22 $13,198 - $22,281	-1,050 Reduced 6.39%	15,375 $326,000
Q4 2020 Feb 10, 2021	BUY	$8.73 - $14.56 $12,833 - $21,403	1,470 Added 9.83%	16,425 $217,000
Q3 2020 Nov 12, 2020	SELL	$8.56 - $11.6 $29,617 - $40,136	-3,460 Reduced 18.79%	14,955 $132,000
Q2 2020 Aug 13, 2020	BUY	$6.63 - $12.85 $122,091 - $236,632	18,415 New	18,415 $184,000

5.45M

3.6K

14.6K

Ticker ICAD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 25,333,900
Market Cap $42.6M
Description
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.